Cite
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
MLA
Zittoun, R. A., et al. “Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne Dell’Adulto (GIMEMA) Leukemia Cooperative Groups.” The New England Journal of Medicine, vol. 332, no. 4, Jan. 1995, pp. 217–23. EBSCOhost, https://doi.org/10.1056/NEJM199501263320403.
APA
Zittoun, R. A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., & et. al. (1995). Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups. The New England Journal of Medicine, 332(4), 217–223. https://doi.org/10.1056/NEJM199501263320403
Chicago
Zittoun, R A, F Mandelli, R Willemze, T de Witte, B Labar, L Resegotti, F Leoni, et al. 1995. “Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne Dell’Adulto (GIMEMA) Leukemia Cooperative Groups.” The New England Journal of Medicine 332 (4): 217–23. doi:10.1056/NEJM199501263320403.